Doseology Sciences Inc. (CSE:MOOD)

Market Cap	1.44M -65.4%
Revenue (ttm)	n/a
Net Income	n/a
EPS	n/a
Shares Out	8.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Open	0.1800
Previous Close	0.1250
Day's Range	0.1800 - 0.1800
52-Week Range	0.0800 - 1.0000
Beta	-2.70
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Doseology Sciences

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc....

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MOOD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error